identification of leishmania species from different parts of iran using a random amplified polymorphic dna in humans, animal reservoirs and vectors
Authors
abstract
in this study, we used random amplified polymorphic dna (rapd) for identification of 17 isolates of leishmania from the skin and reticuloendothelial system of humans, animal reservoirs (rodent and dog) and sandflies in various parts of iran in the last decade. fifteen species have been confirmed by isoenzyme characterization by the london school of hygiene and tropical medicine and shiraz university of medical sciences. in this study, strong confirmation has been observed between random amplified polymorphic dna with isoenzyme characterization.
similar resources
IDENTIFICATION OF LEISHMANIA SPECIES FROM DIFFERENT PARTS OF IRAN USING A RANDOM AMPLIFIED POLYMORPHIC DNA IN HUMANS, ANIMAL RESERVOIRS AND VECTORS
In this study, we used Random Amplified Polymorphic DNA (RAPD) for identification of 17 isolates of Leishmania from the skin and reticuloendothelial system of humans, animal reservoirs (rodent and dog) and sandflies in various parts of Iran in the last decade. Fifteen species have been confirmed by isoenzyme characterization by the London School of Hygiene and Tropical Medicine and Shiraz ...
full textIdentification of Leishmania Species Causing Cutaneous Leishmaniasis Using Random Amplified Polymorphic DNA (RAPD-PCR) in Kharve, Iran
Background: Leishmaniasis, especially cutaneous leishmaniasis, is considered an important health problem in many parts of Iran including Kharve, Khorasan Razavi province. Cutaneous leishmaniasis is caused by various species of Leishmania, each having a different secondary host. Thus, identifying the parasites’ specie is of paramount importance for containment strategy planning. The morpho...
full textidentification of leishmania species isolated from human cutaneous leishmaniasis, using random amplified polymorphic dna (rapd-pcr)
this cross-sectional study was designed to isolate of leishmania spp from cutaneous leishmaniasis patients and characterized them by rapd-pcr technique. eighty- seven leishmania isolates from 112 samples were collected from cutaneous leishmaniasis (cl) patients who referred to mashhad health centers from august 2002 to may 2004. desirable samples (87 isolates) were characterized by rapd-pcr met...
full textidentification of leishmania species causing cutaneous leishmaniasis using random amplified polymorphic dna (rapd-pcr) in kharve, iran
background: leishmaniasis, especially cutaneous leishmaniasis, is considered an important health problem in many parts of iran including kharve, khorasan razavi province. cutaneous leishmaniasis is caused by various species of leishmania, each having a different secondary host. thus, identifying the parasites’ specie is of paramount importance for containment strategy planning. the morphologica...
full textRandom amplified polymorphic DNA (RAPD) fingerprinting of Mycoplasma gallisepticum isolates from chickens
Ten field isolates of Mycoplasma gallisepticum (MG) from different geographical areas of Iran were analyzed by random amplification of polymorphic DNA (RAPD). RAPD analysis produced reproducible banding patterns on the basis of which various distinct amplification patterns could be detected. MG isolates compared with reference strains (S6 and Mg SS) and vaccine strain (ts-11) and demonstrated...
full textMolecular Characterization of Iraqi Local Goat Breeds Using Random Amplified Polymorphic DNA Markers
Cashmere is only produced from Maraz (Kurdi) goat breed in Iraqi Kurdistan Region. The objective of this study was to assess the genetic diversity of different Maraz color types, black goat and Shami breeds using random amplified polymorphic DNA (RAPD) markers. Fourteen primers were used and nine out of them were selected based on their number of bands (NB) and polymorphic characteristics. Thes...
full textMy Resources
Save resource for easier access later
Journal title:
medical journal of islamic republic of iranجلد ۱۵، شماره ۴، صفحات ۲۴۳-۲۴۶
Keywords
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023